Published in Atherosclerosis on October 01, 2011
Red cell distribution width, haemoglobin A1c and incidence of diabetes mellitus. J Intern Med (2014) 2.85
Incidence of severe knee and hip osteoarthritis in relation to different measures of body mass: a population-based prospective cohort study. Ann Rheum Dis (2008) 2.35
Intra-abdominal hypertension and abdominal compartment syndrome after endovascular repair of ruptured abdominal aortic aneurysm. Eur J Vasc Endovasc Surg (2011) 2.26
Diabetes, prediabetes and cancer mortality. Diabetologia (2010) 2.22
New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR). J Intern Med (2010) 2.09
Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients. Diabetologia (2008) 1.90
von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J (1991) 1.83
Sleep as restitution: an introduction. J Intern Med (2003) 1.77
Assessing the effect of interaction between an FTO variant (rs9939609) and physical activity on obesity in 15,925 Swedish and 2,511 Finnish adults. Diabetologia (2009) 1.62
The Scandinavian Propaten(®) trial - 1-year patency of PTFE vascular prostheses with heparin-bonded luminal surfaces compared to ordinary pure PTFE vascular prostheses - a randomised clinical controlled multi-centre trial. Eur J Vasc Endovasc Surg (2011) 1.61
Multicentre prospective study of fascial closure rate after open abdomen with vacuum and mesh-mediated fascial traction. Br J Surg (2011) 1.60
Changes in body mass index following newly diagnosed type 2 diabetes and risk of cardiovascular mortality: a cohort study of 8486 primary-care patients. Diabetes Metab (2013) 1.55
Acute right ventricular dilatation in response to ischemia significantly impairs left ventricular systolic performance. Circulation (1999) 1.53
Colonic ischaemia and intra-abdominal hypertension following open repair of ruptured abdominal aortic aneurysm. Br J Surg (2009) 1.51
Patient specific biomodel of the whole aorta - the importance of calcified plaque removal. Vasa (2011) 1.48
Open abdomen treatment after aortic aneurysm repair with vacuum-assisted wound closure and mesh-mediated fascial traction. Eur J Vasc Endovasc Surg (2013) 1.48
Ceruloplasmin and atrial fibrillation: evidence of causality from a population-based Mendelian randomization study. J Intern Med (2013) 1.47
High concentration of thrombomodulin in plasma is associated with hemorrhage: a prospective study in patients receiving long-term anticoagulant treatment. Circulation (1997) 1.47
Risk factors for fragility fracture in middle age. A prospective population-based study of 33,000 men and women. Osteoporos Int (2006) 1.44
Percutaneous closure of large femoral artery access with Prostar XL in thoracic endovascular aortic repair. Eur J Vasc Endovasc Surg (2013) 1.41
Selective screening for abdominal aortic aneurysm among patients referred to the vascular laboratory. Eur J Vasc Endovasc Surg (2008) 1.41
Von Willebrand factor predicts major bleeding and mortality during oral anticoagulant treatment. J Intern Med (2011) 1.41
Are there differences of inflammatory bio-markers between diabetic and non-diabetic patients with critical limb ischemia? Int Angiol (2006) 1.41
Risk of new aneurysms after surgery for popliteal artery aneurysm. Br J Surg (2008) 1.40
Diagnostic value of disease history, clinical presentation, and inflammatory parameters of appendicitis. World J Surg (1999) 1.39
Invited commentary for "From innumeracy to insight: the uncertainty of help versus harm in treatment of asymptomatic aortic aneurysms" by Legemate and Bossuyt. Eur J Vasc Endovasc Surg (2006) 1.39
Distinction between acute and chronic type B aortic dissection: is there a sub-acute phase? Eur J Vasc Endovasc Surg (2013) 1.37
Evidence that vildagliptin attenuates deterioration of glycaemic control during 2-year treatment of patients with type 2 diabetes and mild hyperglycaemia. Diabetes Obes Metab (2008) 1.33
Repeated clinical and laboratory examinations in patients with an equivocal diagnosis of appendicitis. World J Surg (2000) 1.32
C-reactive protein, metabolic syndrome and incidence of severe hip and knee osteoarthritis. A population-based cohort study. Osteoarthritis Cartilage (2008) 1.30
Association between dietary meat consumption and incident type 2 diabetes: the EPIC-InterAct study. Diabetologia (2012) 1.29
Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes. J Hum Hypertens (2007) 1.29
The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC-InterAct study. Diabetologia (2012) 1.28
Chronic psychosocial stress predicts long-term cardiovascular morbidity and mortality in middle-aged men. Eur Heart J (2004) 1.24
Neisseria gonorrhoeae. Colony variation II. Acta Pathol Microbiol Scand B Microbiol Immunol (1971) 1.22
Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort. Int J Obes (Lond) (2012) 1.21
Diagnostic accuracy of plasma biomarkers for intestinal ischaemia. Scand J Clin Lab Invest (2008) 1.20
Antihyperglycaemic treatment of type 2 diabetes: results from a national diabetes register. Diabetes Metab (2007) 1.15
Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study. Diabetologia (2011) 1.13
Efficacy and tolerability of vildagliptin in drug-naïve patients with type 2 diabetes and mild hyperglycaemia*. Diabetes Obes Metab (2007) 1.11
Weight change and mortality: the Nord-Trøndelag Health Study. J Intern Med (2005) 1.11
Microalbuminuria and risk factors in type 1 and type 2 diabetic patients. Diabetes Res Clin Pract (2005) 1.09
A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease versus normal aging and frontotemporal dementia. Dement Geriatr Cogn Disord (2007) 1.07
Serum lipids, glucose and insulin levels in healthy schoolchildren aged 9 and 15 years from Central Sweden: reference values in relation to biological, social and lifestyle factors. Scand J Clin Lab Invest (2005) 1.07
D-dimer testing in patients with suspected acute thromboembolic occlusion of the superior mesenteric artery. Br J Surg (2004) 1.05
Why does the clinical diagnosis fail in suspected appendicitis? Eur J Surg (2000) 1.03
Dietary fat intake and early mortality patterns--data from The Malmö Diet and Cancer Study. J Intern Med (2005) 1.03
Socio-economic characteristics and quality of life in diabetes mellitus--relation to metabolic control. Scand J Public Health (1999) 1.02
The intracellular localization of two antigens after uptake in vivo by peritoneal macrophages from normal mice. Immunology (1969) 1.02
Obesity and cardiovascular risk factors in type 2 diabetes: results from the Swedish National Diabetes Register. J Intern Med (2006) 1.02
Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up. Circulation (1993) 1.01
Plasma markers of inflammation and incidence of hospitalisations for COPD: results from a population-based cohort study. Thorax (2008) 1.01
Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: a real-life worldwide observational study (EDGE). Int J Clin Pract (2013) 1.00
Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease. Eur Heart J (1989) 1.00
Preliminary study of D-dimer as a possible marker of acute bowel ischaemia. Br J Surg (2001) 0.99
Acute haematogenous osteomyelitis due to type-B haemophilus influenzae. Lancet (1966) 0.99
Vitamin A supplementation and BCG vaccination at birth may affect atopy in childhood: long-term follow-up of a randomized controlled trial. Allergy (2013) 0.98
Interrelationships between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein (a), and established cardiovascular risk factors in a north Swedish population. Atherosclerosis (1989) 0.98
Low and high circulating cortisol levels predict mortality and cognitive dysfunction early after stroke. J Intern Med (2004) 0.97
Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): the Söderåkra Cardiovascular Risk Factor Study. Diabetes Metab (2009) 0.96
Combined seropositivity for H. pylori and C. pneumoniae is associated with age, obesity and social factors. J Cardiovasc Risk (2000) 0.95
Increased abdominal obesity, adverse psychosocial factors and shorter telomere length in subjects reporting early ageing; the MONICA Northern Sweden Study. Scand J Public Health (2008) 0.94
Epidemiological studies of the non-specific effects of vaccines: II--methodological issues in the design and analysis of cohort studies. Trop Med Int Health (2009) 0.94
Mid-upper-arm-circumference and mid-upper-arm circumference z-score: the best predictor of mortality? Eur J Clin Nutr (2012) 0.92
Current prevalence of abdominal aortic aneurysm in 70-year-old women. Br J Surg (2012) 0.91
Risk factors for cardiovascular disease and future osteoarthritis-related arthroplasty: a population-based cohort study in men and women from Malmö, Sweden. Scand J Rheumatol (2011) 0.91
The Landry-Guillain-Barré syndrome. A survey and a clinical report of 127 cases. Acta Neurol Scand (1967) 0.91
Clinical course and prognosis of never-smokers with severe alpha-1-antitrypsin deficiency (PiZZ). Thorax (2008) 0.90
Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris. Eur Heart J (1991) 0.89
Abdominal aortic aneurysm--to screen or not to screen. Eur J Vasc Endovasc Surg (2007) 0.89
Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR). Diabet Med (2009) 0.89
The effect of streptokinase neutralizing antibodies on fibrinolytic activity and reperfusion following streptokinase treatment in acute myocardial infarction. J Intern Med (2002) 0.88
Early and long-term outcome after thoracic endovascular aortic repair (TEVAR) for acute complicated type B aortic dissection. Eur J Vasc Endovasc Surg (2010) 0.87
Associations of HbA1c and educational level with risk of cardiovascular events in 32,871 drug-treated patients with Type 2 diabetes: a cohort study in primary care. Diabet Med (2013) 0.86
Improved fibrinolysis by intense lifestyle intervention. A randomized trial in subjects with impaired glucose tolerance. J Intern Med (1999) 0.86
The clinical importance of monitoring intra-abdominal pressure after ruptured abdominal aortic aneurysm repair. Scand J Surg (2008) 0.86
Endurance physical activity, diet and fibrinolysis. Atherosclerosis (1994) 0.86
Effect of verapamil on accumulation of free and esterified cholesterol in the thoracic aorta of cholesterol-fed rabbits. Atherosclerosis (1986) 0.86
Randomised controlled short-term intervention pilot study on rye bran bread in prostate cancer. Eur J Cancer Prev (2003) 0.85
The Landry-Guillain-Barré syndrome. A review of the literature with a brief report on 127 patients. Dan Med Bull (1967) 0.85
Lactate levels predict mortality and need for peritoneal dialysis in children undergoing congenital heart surgery. Acta Anaesthesiol Scand (2011) 0.85
Intra-abdominal hypertension and abdominal compartment syndrome following surgery for ruptured abdominal aortic aneurysm. Eur J Vasc Endovasc Surg (2006) 0.85
Insulin sensitivity increase after calcium supplementation and change in intraplatelet calcium and sodium-hydrogen exchange in hypertensive patients with Type 2 diabetes. Diabet Med (2009) 0.84
No adverse events after simultaneous administration of 50 000 IU vitamin A and Bacille Calmette-Guerin vaccination to normal-birth-weight newborns in Guinea-Bissau. Eur J Clin Nutr (2007) 0.84
4D-PET/CT with [(11)C]-PK11195 and [(11)C]-(D)-deprenyl does not identify the chronic inflammation in asymptomatic abdominal aortic aneurysms. Eur J Vasc Endovasc Surg (2013) 0.84
Changes in the management of infrarenal abdominal aortic aneurysm disease in Sweden. Br J Surg (2013) 0.83
One-year follow-up after open abdomen therapy with vacuum-assisted wound closure and mesh-mediated fascial traction. World J Surg (2013) 0.83
The association between hyperglycemia and fracture risk in middle age. A prospective, population-based study of 22,444 men and 10,902 women. J Clin Endocrinol Metab (2007) 0.83
A comparative study of extra- and intraluminal sigmoid colonic tonometry to detect colonic hypoperfusion after operation for abdominal aortic aneurysm. Eur J Vasc Endovasc Surg (2011) 0.82
Blood collection in strong acidic citrate anticoagulant used in a study of dietary influence on basal tPA activity. Thromb Haemost (1989) 0.82
Mortality risks among heavy-smokers with special reference to women: a long-term follow-up of an urban population. Eur J Epidemiol (2007) 0.82
Gender-specific differences in carotid intima-media thickness and its progression over three years: a multicenter European study. Nutr Metab Cardiovasc Dis (2011) 0.81
Intravascular ultrasound with a vector phased-array probe (AcuNav) is feasible in endovascular abdominal aortic aneurysm repair. Acta Radiol (2009) 0.81
Incidence of hand eczema in a population-based twin cohort: genetic and environmental risk factors. Br J Dermatol (2007) 0.81
Dyslipidaemia and impaired well-being in middle-aged women reporting low Sense of Coherence. The Women's Health in the Lund Area (WHLA) Study. Scand J Prim Health Care (2000) 0.81
Increased levels of plasma thrombomodulin are associated with vascular and all-cause mortality in patients on long-term anticoagulant treatment. Eur Heart J (1996) 0.81
Antiatherogenic effect of olive and corn oils in cholesterol-fed rabbits with the same plasma cholesterol levels. Arteriosclerosis (1988) 0.80